Evidence map›Paper›PMID 33092205›Full record

ReviewMolecules (Basel, Switzerland)2020

Roles of NAD

Peilin Yu, Xiaobo Cai, Yan Liang, Mingxiang Wang, Wei Yang

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Roles of TRPM channels in glioma.Cancer biology & therapy · 2024
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Prognostic value of nicotinamide adenine dinucleotide (NADJournal of gastrointestinal oncology · 2022
    Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Peilin YuDepartment of Toxicology, and Department of Medical Oncology of Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, Zhejiang, China.
Xiaobo CaiDepartment of Biophysics, and Department of Neurosurgery of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, Zhejiang, China.
Yan LiangDepartment of Toxicology, and Department of Medical Oncology of Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, Zhejiang, China.
Mingxiang WangBrioPryme Biologics, Inc., Hangzhou 310058, Zhejiang, China.
Wei YangDepartment of Biophysics, and Department of Neurosurgery of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, Zhejiang, China.ORCID 0000-0003-3065-1843
First Affiliated Hospital Zhejiang University · CNSecond Affiliated Hospital of Zhejiang University · CN

Funding

Natural Science Foundation of China 31872796, 81371302Zhejiang Provincial Natural Science Foundation LY19B020013
6 · The paper itself

Abstract

Nicotinamide adenine dinucleotide (NAD

Indexed as

CalciumCalcium ChannelsCalcium SignalingCarcinogenesisHumansNADNeoplasmsNeovascularization, PathologicTransient Receptor Potential ChannelsTRPM Cation ChannelsCalciumCalcium ChannelsMCOLN1 protein, humanNADTransient Receptor Potential ChannelsTRPM2 protein, humanTRPM Cation Channelscalcium channelscancermetabolitesNAD+

Identifiers

PMID33092205
PMCPMC7587972
OpenAlexW3093982368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.